An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.
about
EGF receptor ligands: recent advancesTargeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer TherapyPGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway.Database-independent Protein Sequencing (DiPS) Enables Full-length de Novo Protein and Antibody Sequence Determination.Significance of epidermal growth factor receptor signaling for acquisition of meiotic and developmental competence in mammalian oocytes.ADAM17 inhibition enhances platinum efficiency in ovarian cancer.Hypoxia-inducible factor 2-alpha-dependent induction of amphiregulin dampens myocardial ischemia-reperfusion injury.Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulin-mediated activation of the MAP kinase ERK in gut epithelial cancer cells.Systemic and specific effects of antihypertensive and lipid-lowering medication on plasma protein biomarkers for cardiovascular diseases.Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth
P2860
Q28066531-66131BB5-BEB3-442F-93E1-D7B2ECF30B67Q28078129-B3DC0AA0-F4EA-4C4B-B4E9-7F1BE6964148Q33761715-C9D2BD72-23AD-4B00-9B7E-DACA17F6F590Q36797398-F6E03860-5A9A-4371-B536-299EB206FEB5Q37697198-075F9518-684C-405C-9E8F-9967CE4640A2Q38705370-56605A50-AAF9-4843-87E9-9A8573F6CA92Q47913256-0DC1B5CC-26BD-4C29-8F8D-74DECD4FA971Q48511028-A31BC2A6-53A0-4293-A655-CFCBD2D6551AQ52584359-AAFFBEDA-CD90-4297-AE9D-29E709CAF187Q52684329-57B7A8F0-EF64-40D5-9201-B2D5C4E5271DQ54114892-5D0A5018-80E8-48DE-93F9-EF65338341EBQ55085404-5C1C4BB7-D8C8-4CB3-8CA1-2956ADB0D9EFQ58113101-ED9D911E-017B-47A3-AA7C-9EE7029E6A49
P2860
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
An antibody to amphiregulin, a ...... uids, inhibits ovarian tumors.
@en
An antibody to amphiregulin, a ...... uids, inhibits ovarian tumors.
@nl
type
label
An antibody to amphiregulin, a ...... uids, inhibits ovarian tumors.
@en
An antibody to amphiregulin, a ...... uids, inhibits ovarian tumors.
@nl
prefLabel
An antibody to amphiregulin, a ...... uids, inhibits ovarian tumors.
@en
An antibody to amphiregulin, a ...... uids, inhibits ovarian tumors.
@nl
P2093
P2860
P356
P1433
P1476
An antibody to amphiregulin, a ...... luids, inhibits ovarian tumors
@en
P2093
A Abdul-Hai
I Barshack
S Carvalho
P2860
P2888
P304
P356
10.1038/ONC.2015.93
P407
P577
2015-04-27T00:00:00Z